Tesla(US:TSLA) Sou Hu Cai Jing·2026-01-01 11:43Group 1: Neuralink Developments - Neuralink has announced that it will begin mass production of its brain-computer interface devices in 2026, marking a transition from medical experimentation to standardized industrial products [3][4] - The company aims to streamline and automate surgical procedures related to the brain-computer interface technology, although this ambition raises ethical concerns regarding the risks of invasive procedures and potential irreversible damage to brain tissue [3][4] - There are warnings about the misuse of sensitive neural data and the potential infringement on human autonomy if regulatory frameworks are not established [3][4] Group 2: Tesla's Full Self-Driving (FSD) System - A Tesla owner successfully completed a 4,500-kilometer journey across the United States using the latest version of the FSD system with minimal human intervention, generating significant public interest [5] - Regulatory bodies, including the National Highway Traffic Safety Administration (NHTSA), have expressed caution, expanding their safety investigation into the FSD software due to previous incidents of violations [5] - A California court has ruled that Tesla misled consumers regarding the capabilities of its "Autopilot" and FSD systems, suggesting that the naming implies a level of autonomy that is not currently achievable [5]